Literature DB >> 7249300

Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolism.

R L Feldman, W W Nichols, C J Pepine, C R Conti.   

Abstract

The acute coronary hemodynamic and metabolic effects of intravenous dipyridamole were studied in 13 patients. Total left ventricular (LV), anterior (supplied by the left anterior descending coronary artery) and inferior (supplied by circumflex and right coronary arteries) regional flows and metabolic responses were assessed from the coronary sinus and great cardiac vein. Perfusion to LV regions was classified as potentially "normal" or "abnormal," based on coronary angiographic findings. Before dipyridamole, coronary flow, LV oxygen delivery and lactate extraction in both the normal and abnormal regions were similar. Within 1 minute after injection of 20 mg of dipyridamole by i.v. bolus, total coronary flow increased 51% (p less than 0.05). Fifteen minutes after injection the flow increase persisted. Flow decreased to approximately control level by 20 minutes. The major component of this increased total coronary flow resulted from increased flow in normal regions (75% at 1 minute, p less than 0.05). Mean regional LV oxygen delivery and lactate extraction were not changed significantly in either normal or abnormal regions. However, lactate production occurred more often after dipyridamole in abnormal regions. These results suggest that during dipyridamole-induced hyperemia, regional coronary flow and metabolic responses depend upon the status of the arteries supplying the LV region. Regional differences in flow and metabolism occur independent of major changes in heart rate and aortic and LV pressures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249300     DOI: 10.1161/01.cir.64.2.333

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Pharmacologic stress testing: new methods and new agents.

Authors:  Robert C Hendel; Tariq Jamil; David K Glover
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 2.  New perspectives in the drug treatment of Kawasaki disease.

Authors:  D Shingadia; S T Shulman
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

3.  Acute haemodynamic effects of felodipine in congestive heart failure.

Authors:  H Emanuelsson; A Hjalmarson; S Holmberg; F Waagstein
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.

Authors:  M F Rousseau; M F Vincent; P Cheron; G van den Berghe; A A Charlier; H Pouleur
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 5.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

6.  Myocardial infarction during adenosine stress test.

Authors:  J E Polad; L M Wilson
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

7.  Dipyridamole echocardiography: the bedside stress test for coronary artery disease.

Authors:  M B Buchalter; J P Bourke; A Heads; T Hawkins
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

8.  Effects of dipyridamole on collateral flow and regional myocardial function in conscious dogs with newly developed collaterals.

Authors:  M Fujita; A Mikuniya; D P McKown; M D McKown; D Franklin
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

9.  Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.

Authors:  M Fukazawa; J Fukushige; T Takeuchi; H Narabayashi; H Igarashi; T Hijii; K Ueda; Y Kuwabara; M Otsuka; Y Ichiya
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

10.  Identification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile-SPECT.

Authors:  F M Baer; K Smolarz; P Theissen; E Voth; H Schicha; U Sechtem
Journal:  Int J Card Imaging       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.